Our People

Dr Calabria has completed a PhD (UNSW Australia), a Master in Clinical Psychology (Australian National University) and a Bachelor of Psychology with Honours (Macquarie University). She has also completed training focused on diagnostic assessment.

Dr Calabria is a member of the Australian Clinical Psychologists Association (ACPA) and the League of Autistic Psychologists and Affirming Colleagues (LOAPAC).

In 2025, Dr Calabria was appointed as the Deputy-Chair of the Therapeutic Support Panel for Children and Young People (ACT Government) that promotes wellbeing for at-risk children and young people and supports them, their families and the broader community in Canberra.

In 2025, Bianca was also appointed as a professional/research member of the Reference Group that provides strategic guidance on the implementation of the National Autism Strategy and future actions (Federal Government).

In her clinical role, Bianca supports people to increase their wellbeing, connect with their authentic self and improve daily functioning.

Bianca also works with neurodivergent and neurotypical people who have experienced complex trauma.

Her therapeutic approaches include Accelerated Experiential Dynamic Psychotherapy (AEDP), Deep Brain Re-orienting (DBR), Internal Family Systems (IFS), parts psychology, and Eye Movement Desensitisation Reprossing (EMDR). She also supports individuals with supportive counselling and coaching.

Bianca uses strengths-based, trauma-informed, culturally inclusive, person-centred and strengths-based approaches while working collaboratively with clients.

Dr Calabria has worked in research for over 18 years in the areas of wellbeing and trauma. Her research is informed by participatory action research principles and implementation science.

Dr Calabria’s research has included working with Aboriginal and Torres Strait Islander people, services, and communities.

She supervises and mentors Indigenous and non-Indigenous research and clinical students, and provides individual and group supervision to psychologists.

Bianca is an investigator on the Yukaaywa Purrary (YP) Study, that aims to develop and design a new national Aboriginal and Torres Strait Islander child and adolescent wellbeing study. The YP Study team are based at Yardhura Walani (National Centre for Aboriginal and Torres Strait Islander Wellbeing Research) at the Australian National University (ANU).

Dr Bianca Calabria has authored 47 peer reviewed publications and 27 reports (including 2 treatment manuals and 1 article in The Conversation).

Dr Bianca Calabria’s Publication List

Peer Reviewed Papers

1. Flower, R. L., Benn, R., Bury, S.,…Calabria, B.,…et al. (in press). Defining neurodiversity-affirming psychology practice for Autistic adults: A Delphi study integrating psychologist and client perspectives, Autism in Adulthood.

2. Perera, N., Tsey, K., Heyeres., … Calabria., B., … et al. (2022). “We are not stray leaves blowing about in the wind”: exploring the impact of Family Wellbeing empowerment research, 1998 – 2021. International Journal of Equity in Health. 21 (1). DOI: https://doi.org/10.1186/s12939-021-01604-1

3. Bourke, S. C., Chapman, J., Jones, R., Brinckley, M-M., Thurber, K. A., Calabria, B., et al. (2022). Developing Aboriginal and Torres Strait Islander cultural indicators: an overview from Mayi Kuwayu, the National Study of Aboriginal and Torres Strait Islander Wellbeing. International Journal of Equity and Health, 21(1):109. DOI: 10.1186/s12939-022-01710-8.

4. Troung, M., Sharif, M., Olsen, A., Pasalich, D., Calabria, B., & Priest, N. (2022). Attitudes and beliefs about family and domestic violence in faith-based communities: An exploratory qualitative study. Australian Journal of Social Issues. DOI: https://doi.org/10.1002/ajs4.210

5. Brinckley, M-M., Calabria, B., Walker, J., Thurber, K., & Lovett, R. (2021). Reliability, validity, and clinical utility of a culturally modified Kessler scale (MK-K5) in the Aboriginal and Torres Strait Islander population. BMC Public Health, 21, 1111. DOI: 10.1186/s12889-021-11138-4

6. Voce, A., Burns, R., Castle, D., Calabria, B., & McKetin, R. (2021). A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use. Psychiatry Research. 298) DOI: https://doi.org/10.1016/j.psychres.2021.113760

7. Calabria, B., Salinas-Perez, J. A., Tabatabaei-Jafari, H., Mendoza, J., Bell, T., et al. (2021). Alcohol and other drug service availability, capacity and diversity in urban and rural Australia: an integrated atlas. Journal of Studies on Alcohol and Drugs, 82(3), 401-413. DOI: 10.15288/jsad.2021.82.401 2 / 8

8. Thurber, K., Colonna,, E., Wells, S., … Calabria, B., … et al. (2020). Data for action: The Family and Community Safety for Aboriginal and Torres Strait Islander peoples (FaCtS) Study. Australian Aboriginal Studies. 20 (1).

9. Snijder, M., et al. (2020). “We walked side by side through the whole thing”: a mixed methods study of key elements of community-based participatory research partnerships between rural Aboriginal communities and researchers. Australian Journal of Rural Health.

10.Snijder, M., Calabria, B., Dobbins, T., Shakeshaft, A. (2020). Factors associated with alcohol-related injuries for Aboriginal and non-Aboriginal Australians: an observational study. International Journal of Environmental Research and Public Health 17: 387.

11.Calabria, B., et al. (2020). Reducing drug and alcohol use and improving well-being for Indigenous and non-Indigenous Australians using the Community Reinforcement Approach: a feasibility and acceptability study. Int J Psychol.

12.Pettit, S.. et al. (2019). Holistic primary health care for Aboriginal and Torres Strait Islander prisoners: Exploring the role of Aboriginal Community Controlled Health Organisations. ANZJPH.

13.Voce, A., et al. (2019). Is there a discrete negative symptom syndrome in people who use methamphetamine?, Comprehensive Psychiatry.

14.Voce, A., et al. (2019). A systematic review of the symptom profile and course of methamphetamine associated psychosis, Substance Use and Misuse.

15.Voce, A., et al. (2018). The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses, Psychiatry Res, 265, 19-24.

16.GBD 2016 Alcohol Collaborators. (2018). Alcohol use and burden: a systematic analysis from the Global Burden of Disease Study 2016 for 195 countries and territories, 1990–2016. Lancet.

17.Tong, A., et al. (2018). General practitioners’ perspectives on the prevention of cardiovascular disease: systematic review and thematic synthesis of qualitative studies. BMJ Open.

18.Paige, E., et al. (2018). Socioeconomic variation in absolute cardiovascular disease risk and treatment in the Australian population. Prev Med, 114, 217-222

19.Calabria et al. (2018). Absolute cardiovascular disease risk and use of lipid-lowering therapy among Aboriginal and Torres Strait Islander people: evidence to optimise prevention. MJA, 209, 35-41. 3 / 8

20.Snijder, M., et al. (2018). A need for tailored programs and policies to reduce rates of alcohol-related crimes for vulnerable communities and young people: an analysis of routinely collected police data. Alcohol & Alcoholism, 53, 578-585.

21.Thurber, K., et al. (2018). 'Telling our story... creating our own history’: caregivers’ reasons for participating in an Australian longitudinal study of Indigenous children. Int J Equity Health.

22.Lokuge, K., et al. (2017). Indigenous health program evaluation design and methods in Australia: a systematic review of the evidence. ANZPH, 41, 480-2.

23.Korda, R. et al. (2016). Socioeconomic variation in incidence of primary and secondary major cardiovascular disease events: an Australian population-based prospective cohort study. Int J Equity Health. 15, 189.

24.GBD 2015 mortality and causes of death collaborators, and others. (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 10053.

25.GBD 2015 disease and injury incidence and prevalence collaborators, and others. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990– 2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 10053.

26.GBD 2015 DALYS and hale collaborators, and others. (2016). Global, regional, and national disabilityadjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 10053.

27.GBD 2015 risk factors collaborators, and others. (2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 10053.

28.Snijder, M., et al. (2015). A systematic review of studies evaluating Australian indigenous community development projects: the extent of community participation, their methodological quality and their outcomes. BMC Public Health, 15, 1154.

29.Calabria, B., et al. (2014). Identifying Aboriginal-specific AUDIT-C and AUDIT-3 cutoff scores for at-risk, high-risk and likely dependent drinkers using measures of agreement with the 10-item Alcohol Use Disorders Identification Test. Addict Sci Clin Prac, 9, 17.

30.Calabria, B., et al. (2014). Tailoring a family-based alcohol intervention for Aboriginal Australians and the experiences and perceptions of health care practitioners trained in its delivery. BMC Public Health, 14, 322. 4 / 8

31.Calabria, B., et al. (2013). The acceptability to Aboriginal Australians of a family-based intervention to reduce alcohol-related harms. Drug Alcohol Rev, 32, 328-32.

32.Degenhardt, L., et al. (2013). The global epidemiology and contribution of cannabis dependence to the Global Burden of Disease in 2010. PLOS ONE, 8, e76635.

33.Murray, C. J. L., et al. (2013). GBD 2010 country results: a global public good. Lancet, 381, 965-70.

34.Calabria, B., et al. (2012). Systematic review of family-based interventions targeting alcohol misuse and their potential to reduce alcohol-related harm in Indigenous communities. JSAD, 73, 477-88.

35.Calabria, B., et al. (2012). The perceived health risks of cannabis use in an Australian household survey. Drug Alcohol Rev, 31, 809-12.

36.Lim, S. S., et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2224-60.

37.Murray, C. J. L., et al. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2197-223.

38.Salmon, J. A., et al. (2012). Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet, 380, 2129-43.

39.Vos, T., et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2163-96.

40.Calabria, B., et al. (2011). A systematic and methodological review of interventions for young people experiencing alcohol-related harm. Addiction, 106, 1406-18.

41.Degenhardt, L., et al. (2011). What data is available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Dep, 117, 85-101.

42.Degenhardt, L., et al. (2011). Mortality among problematic cocaine users. Drug Alcohol Dep, 113, 88-95.

43.Calabria, B., et al. (2010). Epidemiology of alcohol-related burden of disease among Indigenous Australians. ANZJPH, 34, S47-S51.

44.Calabria, B., et al. (2010). Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence. Addict Beh, 35, 741-9. 5 / 8

45.Calabria, B. (2010). Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev, 29, 318-30.

46.Degenhardt, L., et al. (2009). Should we make burden of disease estimates for cannabis use as a risk factor for psychosis? PLOS Med, 6, e1000133.

47.Swift, W., et al. (2009). Are adolescents who moderate their cannabis use at lower risk of later regular and dependence cannabis use? Addiction, 104, 806-14.

Reports

1. Guthrie, J., et al. (2020). ‘The answers were there before white man come in’: stories of strength and resilience for responding to violence in Aboriginal and Torres Strait Islander communities – Family and Community Safety for Aboriginal and Torres Strait Islander Peoples Study Report.

2. Troung, M., Calabria, B., Sharif, M. Z., Priest, N. (2019). New Study Find Family Violence if Often Poorly Understood in Faith Communities. The Conversation. New study finds family violence is often poorly understood in faith communities (theconversation.com)

3. Troung, M., Sharif, M., Pasalich, D., Olsen, A., Calabria., B., Priest, N. (2020). Faith-based communities’ responses to family and domestic violence. CSRM Working Paper, ANU. Faithbased communities' responses to family and domestic violence: CSRM Working Papers: No. 1/2020 — Monash University

4. Rose, M., et al. (2014). Aboriginal-specific Community Reinforcement and Family Training (CRAFT) training manual. NDARC Technical Report no. 327. NDARC, UNSW Australia.

5. Rose, M., et al. (2014). Aboriginal-specific Community Reinforcement Approach (CRA) training manual. NDARC Technical Report no. 326. NDARC, UNSW Australia.

6. Ali, H., et al. (2010). Searching the grey literature to access information on drugs, alcohol and HIV research: an update. NDARC Technical Report no. 314. NDARC, UNSW Australia.

7. Bucello, C., et al. (2010). What do we know about the extent of cocaine use and dependence? Results of a global systematic review. NDARC Technical Report no. 308. NDARC, UNSW Australia.

8. Calabria, B., et al. (2010). What do we know about the extent of cannabis use and dependence? Results of a global systematic review. NDARC Technical Report no. 307. NDARC, UNSW Australia.

9. Degenhardt, L., et al. (2010). What do we know about the global prevalence of illicit meth/amphetamine use and dependence?. NDARC Technical Report no. 310. NDARC, UNSW Australia. 6 / 8

10.Nelson, P., et al. (2010). What do we know about the extent of heroin and other opioid use and dependence? Results of a global systematic review. NDARC Technical Report no. 309. NDARC, UNSW Australia.

11.Calabria, B., et al. (2009). "Remission" from illicit drug dependence: Systematic reviews of prospective studies investigating the course of amphetamine, cannabis, cocaine and opioid dependence. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 17. Sydney: NDARC, UNSW Australia.

12.Nelson, P., et al. (2009). Methodology used in a systematic review of evidence on the prevalence of heroin/opioids use and dependence. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 16. Sydney: NDARC, UNSW Australia.

13.Bucello, C., et al. (2009). Methodology used in a systematic review of evidence on the prevalence of cocaine use and dependence. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 15. Sydney: NDARC, UNSW Australia.

14.Calabria, B., et al. (2009). Methodology used in a systematic review of evidence on the prevalence of cannabis use and dependence. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 14. Sydney: NDARC, UNSW Australia.

15.Degenhardt, L., et al. (2009). Methodology used in a systematic review of evidence on the prevalence of amphetamine use and dependence. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 13. Sydney: NDARC, UNSW Australia.

16.Baxter, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Anxiety Disorders. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.

17.Baxter, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Schizophrenia. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.

18.Calabria, B., et al. (2008). Searching the grey literature to access information on drug and alcohol research. NDARC Technical Report no. 293. Sydney: NDARC, UNSW Australia. 7 / 8

19.Degenhardt, L., et al. (2008). Overview of injuries/diseases to be included in the comparative risk assessment for regular cannabis use. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 5. Sydney: NDARC, UNSW Australia.

20.Calabria, B., et al. (2008). Cannabis related mortality. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 3. Sydney: NDARC, UNSW Australia.

21.Degenhardt, L., et al. (2008). Cannabis use as a risk factor for mental disorders. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Illicit drugs discussion paper no. 2. Sydney: NDARC, UNSW Australia.

22.Pham, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Bipolar Disorder. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.

23.Pham, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Depressive Disorders. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.

24.Somerville, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Conduct Disorders. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.

25.Somerville, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Attention-Deficit Hyperactivity Disorder. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.

26.Ventura, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Eating Disorders. Global Burden of Disease Mental Disorders and Illicit Drug Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.

27.Ventura, A., et al. (2008). Summary of data collected and decision rules used in making regional and global estimates: Pervasive Developmental Disorders. Global Burden of Disease Mental Disorders and Illicit Drug 8 / 8 Use Expert group, Mental disorders discussion paper. Brisbane: Policy and Economics Group, Queensland Centre for Mental Health Research, University of Queensland.